Related Experiment Videos
Geographical epidemiology of ovarian and testicular germ cell cancers
R H Kamdar1, R T Oliver, N Othieno-Abinya
1Department of Medical Oncology, St Bartholomew's and The Royal London School of Medicine and Dentistry, West Smithfield, UK.
British Journal of Cancer
|December 4, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
OV21/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2012
Prognostic factors for renal cell carcinoma.
Cancer treatment reviews·2008
Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer.
British journal of cancer·2008
Computed tomography features of recurrent ovarian carcinoma according to time to relapse.
Acta radiologica (Stockholm, Sweden : 1987)·2007
A feasibility, pharmacokinetic and frequency-escalation trial of intraperitoneal chemotherapy in high risk gastrointestinal tract cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2007
VISTA drives tumour-intrinsic proliferation in mesothelioma cells.
British journal of cancer·2026
Small extracellular vesicles from the plasma of head and neck cancer patients induce dysfunctional T cell phenotypes.
British journal of cancer·2026
Distinct responses of COL17A1 nonsense variants to readthrough drugs and NOG as a novel enhancer in junctional epidermolysis bullosa.
Molecular therapy. Nucleic acids·2026